A study from China published in the Journal of Clinical Oncology has shown that CAR T-cell therapy that targets CD19 and CD22 is effective at treating recurrent or refractory acute lymphoblastic leukemia in children. Read More
Blog
December 12, 2022 Greg Guthrie, ASCO staff
December 8, 2022 Ichrak Ben Abdallah, MD
In this “Cancer in My Community” post, Dr. Ichrak Ben Abdallah describes what cancer is like in Tunisia, including what drew her to oncology, how people with cancer in Tunisia receive care, and the prevalence of cancers caused by tobacco use in the country. Read More
December 6, 2022 Cordelia Galgut, PhD
Psychologist and cancer survivor Dr. Cordelia Galgut shares what it’s like living with the fear of cancer recurrence, why the fear of recurrence is often misunderstood, and what survivors can do to cope. Read More
December 1, 2022 Brielle Gregory Collins, ASCO staff
In this podcast, Dr. Xiuning Le discusses research from the 2022 North America Conference on Lung Cancer, including 3 studies evaluating targeted therapy treatments for people with non-small cell lung cancer. Read More
November 30, 2022 Jyoti Patel, MD, FASCO
In this month’s “From the Editor in Chief” column, Dr. Jyoti Patel discusses how developing healthy habits can help people with cancer feel more in control and describes 6 habits for improving overall wellness. Read More